4
Changes in Ownership
REGENERON PHARMACEUTICALS, INC. Filed Acc 0001968202-24-000105
Director sold 100 shares at an average $1,059.24 ($105,924)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
RYAN ARTHUR F · Director
Table I: Non-derivative
19 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-07-01 | Sale : show line 1 in the form 10b5-1 | −3 | $1,047.11 | $3,141 | 17,979 | D |
| 2024-07-01 | Sale : show line 2 in the form 10b5-1 | −2 | $1,050.87 | $2,102 | 17,977 | D |
| 2024-07-01 | Sale : show line 3 in the form 10b5-1 | −7 | $1,051.58 | $7,361 | 17,970 | D |
| 2024-07-01 | Sale : show line 4 in the form 10b5-1 | −6 | $1,052.19 | $6,313 | 17,964 | D |
| 2024-07-01 | Sale : show line 5 in the form 10b5-1 | −8 | $1,053.60 | $8,429 | 17,956 | D |
| 2024-07-01 | Sale : show line 6 in the form 10b5-1 | −1 | $1,054.25 | $1,054 | 17,955 | D |
| 2024-07-01 | Sale : show line 7 in the form 10b5-1 | −2 | $1,056.81 | $2,114 | 17,953 | D |
| 2024-07-01 | Sale : show line 8 in the form 10b5-1 | −2 | $1,057.64 | $2,115 | 17,951 | D |
| Open-market sales · 100 sh · avg $1,059.24 · $105,924 | ||||||
Loading xslF345X05/edgardoc.xml…